Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from differentially responsive Toll-like receptor 4 (Tlr4)-normal mice infected with respiratory syncytial virus (RSV)

ABSTRACT: In airway epithelial cells, Tlr4 mediates both innate and adaptive immune responses to viral pathogens through the surface fusion glycoprotein (RSV F), however the mechanism is not well characterized. We used microarrays to identify differential gene expression pathways induced by RSV infection.

ORGANISM(S): Mus musculus

PROVIDER: GSE112956 | GEO | 2019/11/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from Toll-like receptor 4 (Tlr4)-deficient mice infected with respiratory syncytial virus (RSV)

Project description:In airway epithelial cells, Tlr4 mediates both innate and adaptive immune responses to viral pathogens through the surface fusion glycoprotein (RSV F), however the mechanism is not well characterized. We used microarrays to identify Tlr4-mediated gene expression pathways induced by RSV infection.

2019-08-28 | GSE111861 | GEO

Respiratory Syncytial virus (RSV)

Project description:Respiratory Syncytial virus (RSV)

| PRJNA973580 | ENA

Expression data from differentially responsive Toll-like receptor 4 (Tlr4)-normal mice infected with respiratory syncytial virus (RSV)

Project description:Expression data from differentially responsive Toll-like receptor 4 (Tlr4)-normal mice infected with respiratory syncytial virus (RSV)

| PRJNA449611 | ENA

Expression data from Toll-like receptor 4 (Tlr4)-deficient mice infected with respiratory syncytial virus (RSV)

Project description:Expression data from Toll-like receptor 4 (Tlr4)-deficient mice infected with respiratory syncytial virus (RSV)

| PRJNA438431 | ENA

Time course of respiratory syncytial virus (RSV) infection in healthy and cystic fibrosis (CF) human airway epithelial cell cultures

Project description:The goal of this study was to examine changes in gene expression over time in healthy and cystic fibrosis (CF) human airway epithelia infected with RSV.

2023-11-08 | GSE247298 | GEO

Respiratory syncytial virus induces alternative mRNA processing

Project description:we examine the effect of RSV infection in human small airway epithelial cells (hSAECs)

2021-02-26 | GSE167486 | GEO

Respiratory Syncytial Virus (RSV) optimizes the translational landscape during infection

Project description:Viral infection often triggers eukaryotic initiator factor 2α (eIF2α) phosphorylation, leading to global 5’-cap-dependent translation inhibition. RSV encodes messenger RNAs (mRNAs) mimicking 5’-cap structures of host mRNAs and thus inhibition of cap-dependent translation initiation would likely also reduce viral translation. We confirmed that RSV limits widespread translation initiation inhibition and unexpectedly found that the fraction of ribosomes within polysomes increases during infection, indicating higher ribosome loading on mRNAs during infection. We found that AU-rich host transcripts that are less efficiently translated under normal conditions become more efficient at recruiting ribosomes, similar to RSV transcripts. Viral transcripts are transcribed in cytoplasmic inclusion bodies, where the viral AU-rich binding protein M2-1 has been shown to bind viral transcripts and shuttle them into the cytoplasm. We further demonstrated that M2-1 is found on polysomes, and that M2-1 might deliver host AU-rich transcripts for translation.

2024-09-03 | GSE268742 | GEO

Multi-organ profiles of respiratory syncytial virus (RSV)-infected BALB/c mice

Project description:Respiratory syncytial virus (RSV) a leading cause of pediatric and adult morbidity and mortality worldwide. It can cause complications in multiple organs, thus increasing hospital stays and costs. However, RSV-based studies have primarily focused on effects in the lungs and blood, thereby potentially neglecting critical genes and pathways. Hence, studying RSV infection via a novel multi-organ approach is important. In this study, lung, intestine, brain, and spleen tissues from six BALB/c mice (6–8 weeks old; three in control group and three in RSV-infected group) were subjected to RNA sequencing. Differentially expressed genes (DEGs) in each organ were obtained and functional enrichment analysis was performed. We first used CIBERSORT to evaluate the immune-infiltration landscape. Subsequently, common DEGs (co-DEGs) among the four organs were analyzed to identify key genes and pathways. After quantitative reverse transcription-polymerase chain reaction, western blotting, and external validation analysis of key hub genes, their correlation with immune cells and potential functions were explored. We found that the host response to RSV infection varied among the four organs regarding gene expression profiles and immune cell infiltration. Analysis of the 16 co-DEGs indicated enrichment in the platelet and neutrophil degranulation pathways. Importantly, the key gene hemopexin (Hpx) was strongly correlated with the immune cell fraction in the lungs and may participate in the regulation of platelet activation and immune response.

2022-04-24 | GSE197868 | GEO

Respiratory Syncytial virus (RSV) directly binds host microRNAs and de-regulates host gene targets [RNA-seq]

Project description:To investigate RNA expression changes in RSV infection, we performed total RNA-seq from Mock and RSV-infected A549 cells In addition, we investigated the association of RNAs with AGO2 by performing AGO2 immunoprecipitation and total RNA-seq of AGO2-bound RNAs in Mock and RSV-infected A549 cells

2024-05-29 | GSE231788 | GEO

Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours

Project description:Human bronchial epithelial cells (BEAS-2B cells) were treated with RSV at 1.0 MOI for 4 and 24 hours or control (vehicle-treated for 4 hours). Global gene expression was measured by Affy Hu133 plus 2.0 microarray chips. Experiment Overall Design: 4 controls (vehicle-treated for 4 hours) Experiment Overall Design: 4 RSV-treated for 4 hours Experiment Overall Design: 4 RSV-treated for 24 hours

2007-10-02 | E-GEOD-3397 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data